Pharmacologic manipulation of glomerular function (Q40743696)

23 September 2017

1 reference

title

Pharmacologic manipulation of glomerular function (English)

1 reference

23 September 2017

ter Wee PM

1

1 reference

23 September 2017

Donker AJ

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 1994

1 reference

23 September 2017

1 reference

23 September 2017

45

1 reference

23 September 2017

2

1 reference

23 September 2017

417-424

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1994.54

23 September 2017

0 references

cites work

Mechanics of Glomerular Ultrafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Functional adaptation to reduction in renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1994.54

1 reference

7 January 2021

The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

The effect of indomethacin on kidney function and plasma renin activity in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Nature of the glomerular capillary injury in human membranous glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Angiotensin actions in the kidney: Renewed insight into the old hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Increased renal plasma flow in long-term enalapril treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Comparative Effects of Antihypertensives on Proteinuria: Angiotensin-Converting Enzyme Inhibitor Versus α1-Antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of diltiazem and manganese renal hemodynamics: studies in the isolated perfused rat kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Clinical Effects of Intravenous Nifedipine on Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal effects of diltiazem in primary hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of low-dose dopamine on effective renal plasma flow and glomerular filtration rate in 32 patients with IgA glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Serial studies of glomerular filtration rate and renal plasma flow in kidney transplant donors, identical twins, and allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal reserve filtration capacity before and after kidney donation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

The effect of low-dose dopamine on renal haemodynamics in patients with type 1 (insulin-dependent) diabetes does not differ from normal individuals.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Functional response of healthy and diseased glomeruli to a large, protein-rich meal

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Lack of glomerular hemodynamic stimulation after infusion of branched-chain amino acids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

The renal hemodynamic response following a meat meal in children with chronic renal failure and in healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Preservation of renal reserve in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Testing renal reserve filtration capacity with an amino acid solution.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal functional reserve in live related kidney donors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Response to acute protein load in kidney donors and in apparently normal postacute glomerulonephritis patients: evidence for glomerular hyperfiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Loss of renal functional reserve following kidney transplantation and in patients with advanced disorders of liver function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Failure of cyclosporine-treated renal allograft recipients to increase glomerular filtration rate following an amino acid infusion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal function and renal function reserve in insulin-dependent diabetic patients during (near) normoglycaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal hemodynamic changes in humans. Response to protein loading in normal and diseased kidneys.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal hemodynamics during separate and combined infusion of amino acids and dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Renal vascular and thrombotic effects of cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1994.54

1 reference

7 January 2021

Cyclosporin-A deposits in renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.54

7 January 2021

Identifiers

DOI

10.1038/KI.1994.54

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference